know more, do more

Advancing endocrinology and improving public health

Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field. 

the latest
Meetings & Events

ENDO 2022 Pricing Expires on Wednesday

May 16, 2022

Register for ENDO 2022 by this Wednesday, May 18 at 11:59 PM to ensure you take advantage of our Advanced Registration rates before they expire. ENDO welcomes leading experts, researchers, and the most respected clinicians in the field as we share the latest developments in endocrine research and patient care. Do not miss the biggest annual meeting in endocrinology - register today before rates increase!

Meetings & Events

CEU2022 Registration Is Now Open

April 28, 2022

Join us on September 8-10 to discover the latest developments in endocrinology diagnosis and treatments. This year, we are excited to announce our first CEU hybrid experience! For the first time since 2019, we will return to the in-person meeting at the Intercontinental Hotel in Miami, FL. Additionally, our entire program will also be available online. Register by July 28 to secure lowest rates.

Meetings & Events

Menopause: Assessment and Hormonal Treatment

May 02, 2022

Join our member-exclusive, on-demand webinar for a discussion on how to identify women in menopause transition who are best candidates for hormonal treatment (HT). Presenters also will discuss improving benefits while decreasing risks through HT individualization, and more. Watch today.

Meetings & Events

Attend an Ancillary Meeting at ENDO 2022

April 17, 2022

Further your knowledge at ENDO 2022! We invite you to attend one of our ancillary symposia on obesity management, glycemic control, and pediatric achondroplasia. These supplemental activities are available for anyone to participate, including those who do not register for ENDO! The ancillary sessions do, however, require separate registration. Learn more and register.

Advocacy

Advocacy in Action

May 12, 2022

This week, we continue to advocate for access to gender affirming care for minors in the UK and US and for a substantial increase to the NIH base budget in FY2023.

We Are Endocrinology

Deena Adimoolam
“I use media to share a message of prevention and recognition of many endocrine diseases, especially diabetes and obesity. As a member of the Endocrine Society, I have also had the opportunity to continue this work with Society members who share in my vision and passion. I work closely with the Endocrine Society’s Hormone Health Network to spread awareness on various endocrine diseases through patient education tools and media.” – Deena Adimoolam, MD
We are an 18,000 member strong global community
A champion for the Society’s guidelines, Chris has been passionate about improving our guideline development methodology as well as about making guideline content more accessible to readers around the world. – Christopher McCartney, MD

Advantages of Membership

Need more info?

Learn more about the advantages of membership

Endocrine Society News

Stress may be associated with fertility issues in women

May 10, 2022

Female rats exposed to a scream sound may have diminished ovarian reserve and reduced fertility, according to a small animal study published in the Endocrine Society’s journal, Endocrinology.

Hammer wins inaugural Endocrine Images Art Competition

May 10, 2022

Gary Hammer, M.D., Ph.D., Millie Schembechler Professor of Adrenal Cancer at the University of Michigan in Ann Arbor, Mich., won the Endocrine Society's Endocrine Images Art Competition, a contest celebrating the beauty of endocrine science.

Seattle health fair offers free screenings, wellness activities for people with diabetes

May 03, 2022

Endocrine experts will deliver free health services to underrepresented communities, including Latinx and Hispanic residents, during EndoCares® Seattle, an in-person health education event being held on May 14.

View More

Featured Journal Articles

GDF15 in ER stress, β cell, and diabetes

May 17, 2022

We have discovered that growth differentiation factor 15 (GDF15) promotes endoplasmic reticulum stress-induced β-cell apoptosis and that downregulation of GDF15 has beneficial effects on β-cell survival in diabetes.

Lenvatinib for Metastatic Pheo/Paraganglioma

May 17, 2022

We aim to evaluate the efficacy of lenvatinib as salvage therapy in metastatic pheochromocytomas and paragangliomas.

Papillary Thyroid Cancer Recurrence Risk Factors

May 17, 2022

Here analysis of existing next-generation sequencing data was employed to investigate gene expression changes and somatic mutational profiles associated with thyroid cancer recurrence.

View More
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.